###begin article-title 0
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oct3/4 </italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oct4</italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
Target genes of a transcription factor (TF) Pou5f1 (Oct3/4 or Oct4), which is essential for pluripotency maintenance and self-renewal of embryonic stem (ES) cells, have previously been identified based on their response to Pou5f1 manipulation and occurrence of Chromatin-immunoprecipitation (ChIP)-binding sites in promoters. However, many responding genes with binding sites may not be direct targets because response may be mediated by other genes and ChIP-binding site may not be functional in terms of transcription regulation.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 545 552 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 585 592 585 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 887 893 887 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 962 968 962 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
To reduce the number of false positives, we propose to separate responding genes into groups according to direction, magnitude, and time of response, and to apply the false discovery rate (FDR) criterion to each group individually. Using this novel algorithm with stringent statistical criteria (FDR < 0.2) to a compendium of published and new microarray data (3, 6, 12, and 24 hr after Pou5f1 suppression) and published ChIP data, we identified 420 tentative target genes (TTGs) for Pou5f1. The majority of TTGs (372) were down-regulated after Pou5f1 suppression, indicating that the Pou5f1 functions as an activator of gene expression when it binds to promoters. Interestingly, many activated genes are potent suppressors of transcription, which include polycomb genes, zinc finger TFs, chromatin remodeling factors, and suppressors of signaling. Similar analysis showed that Sox2 and Nanog also function mostly as transcription activators in cooperation with Pou5f1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
We have identified the most reliable sets of direct target genes for key pluripotency genes - Pou5f1, Sox2, and Nanog, and found that they predominantly function as activators of downstream gene expression. Thus, most genes related to cell differentiation are suppressed indirectly.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 1114 1115 1114 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1116 1117 1116 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Identification of direct targets of transcription factors (TFs) is a necessary step to reconstruct gene regulatory networks in living cells. Although traditional single-gene experiments (e.g., assaying promoter activity using a promoter-reporter gene construct) remain most reliable in testing direct targets, there is also a need for high-throughput approaches that would allow one to detect the majority of most important target genes. Two experimental methods contribute most to such a high-throughput search of target genes: gene expression profiling of TF-manipulated cells and genome-wide chromatin immunoprecipitation (ChIP) assay. However, expression profiling may yield many genes that respond indirectly, whereas ChIP may yield many non-functional binding sites, i.e., binding sites that were detected by ChIP, but were not functional for transcriptional regulation. Therefore, the state of the art is to take the intersection between these two sets of genes (i.e. select genes that responded to the manipulation of a TF and have binding sites) and consider it as a set of tentative target genes (TTGs) [1,2]. However, the intersection of these sets of genes may still contain numerous false positives - genes that respond indirectly and have non-functional ChIP-binding sites. Another problem is that there is no method to statistically quantify the proportion of false positives in the set of TTGs.
###end p 9
###begin p 10
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
To address these issues, we developed a new method to identify TTGs, which reduces the proportion of false positives by applying the False Discovery Rate (FDR) criterion to individual groups of genes that differ in the direction, magnitude, and time of response to the manipulation of a TF. The computational strategy included optimization of Scores of Potential Function (SPF) of binding sites that separated best the training and control sets of genes, and estimation of the FDR from the frequency distribution of SPF among control genes (Fig. 1).
###end p 10
###begin p 11
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A flow chart showing algorithm used to identify tentative target genes for a transcription factor.</bold>
A flow chart showing algorithm used to identify tentative target genes for a transcription factor. The algorithm includes the optimization of Scores of Potential Function (SPF) based on the comparison of training and control sets of genes, and the estimation of False Discovery Rates (FDR) within individual groups of responding genes.
###end p 11
###begin p 12
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oct3/4</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oct4</italic>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 317 324 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 688 695 688 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 755 761 755 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 868 875 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1173 1180 1173 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1265 1266 1265 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1296 1303 1296 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1333 1340 1333 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1432 1439 1432 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1591 1596 1591 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 1600 1606 1600 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1716 1717 1716 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1871 1872 1871 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1873 1874 1873 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1875 1877 1875 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 999 1004 <span type="species:ncbi:10090">mouse</span>
This method is applied here to the mouse Pou5f1 (Oct3/4, Oct4) gene which is the major TF that controls self-renewal and pluripotency in ES cells [3,4]. Lists of potential target genes of POU5F1 were recently generated using chromatin immunoprecipitation (ChIP) and gene expression profiling of cells with suppressed Pou5f1 transcription [1,5]. Most studies used shRNA for Pou5f1 suppression [1,5], but these methods can generate off-target effects, and gene repression is often weak. In these studies, expression profiling was carried out with 1 day intervals which limited the temporal resolution in detecting gene response. Matoba et al. [2] increased the reliability of prediction of Pou5f1 primary targets by using a tet-inducible system to suppress Pou5f1. This method eliminated false-positives related to potential off-target effects of shRNA used to suppress Pou5f1 in earlier studies. However, gene expression was still measured in 1 day intervals, and microarrays did not include all the mouse genes. In this paper we present a new microarray experiment with the same tet-inducible system but with multiple time points within 24 hr to capture early responses to Pou5f1 suppression. These data were analyzed together with published genome-wide ChIP data [1]. We found that most TTGs of Pou5f1 in ES cells were activated by Pou5f1 and only a limited number of genes were suppressed, which implies that the main function of Pou5f1 binding to promoters of target genes is activation of gene expression rather than suppression. The same method was then applied to find target genes of Sox2 and Nanog based mostly on previously published data. A list of data sets used in this study is shown in Additional file 1. Because the interaction between POU5F1, SOX2, and NANOG is supported by immunoprecipitation, functional analysis, and co-localization of binding sites [6,1-10], we explored the relationships between their target genes. These results are discussed in relation to the mechanism of pluripotency maintenance in ES cells.
###end p 12
###begin title 13
Results and Discussion
###end title 13
###begin title 14
1. Time course microarray data
###end title 14
###begin p 15
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 640 647 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 967 968 967 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1070 1077 1070 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1106 1107 1106 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1156 1158 1156 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1189 1191 1189 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1247 1254 1247 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1276 1277 1276 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1278 1279 1278 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5A</xref>
###xml 1317 1319 1317 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1398 1399 1398 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1455 1462 1455 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1566 1570 1566 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-150</sup>
###xml 1589 1591 1589 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5B</xref>
###xml 1804 1805 1804 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1831 1838 1831 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1870 1872 1870 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1958 1960 1958 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 2093 2094 2093 2094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 2095 2097 2095 2097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
We previously reported time course microarray data of mouse ES cells, in which the level of Pou5f1 expression was reduced in tetracycline (Tet)-controllable manner [2]. Global gene expression profiles were obtained from ES samples at 24, 48, 72, 96, and 120 hr [2]. To obtain earlier effects of Pou5f1 repression, here we used the same ZHBTc4 ES cells [4] and measured the global gene expression profiles at 0, 3, 6, 12, and 24 hr after adding Tet. Because the 24 hr time point was present in both experiments, the microarray data at 24 hr was used to merge two data sets (see Methods) (Additional file 2). In ZHBTc4 ES cells, the level of Pou5f1 mRNA was reduced to one-thirds within 3 hrs after adding Tet, whereas the same reduction of POU5F1 protein level was observed in 6 hrs (Additional file 3). The cells show no morphological changes associated with differentiation during the first 24 hrs after adding Tet, but the cells begin to be flattened after 48 hrs [4]. We found 6197 genes with a statistically significant (FDR <= 0.05, fold change >= 1.5) response to Pou5f1 suppression (Additional file 4). A subset of these genes with > 2 fold change (N = 2600) overlapped reasonably (N = 1319, 50.7%) with gene lists identified earlier using Pou5f1 knockdown with shRNA [5,1] (Additional file 5A). The majority (N = 1185, 96.7%) of 1225 genes common between our study and the published study [1], changed their expression in the same direction after Pou5f1 suppression, which was significantly greater than expected from random matches (chi-square = 685, p = 10-150) (Additional file 5B). Discrepancies between data sets may be explained by off-target effects of shRNA in earlier studies and by a larger coverage of genes in our microarrays. Genes that were previously considered targets of POU5F1 [1], but had no response to Pou5f1 suppression in our experiments (N = 487), were not artifacts of microarray design, because the majority of these genes (N = 442) had functional oligos in our microarray that showed statistically significant differential expression in earlier experiments [2,11].
###end p 15
###begin p 16
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 686 693 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 728 735 728 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1065 1070 1065 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxd3</italic>
###xml 1072 1077 1072 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mybl2</italic>
###xml 1079 1083 1079 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zic3</italic>
###xml 1085 1089 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf2</italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nr0b1</italic>
###xml 1198 1222 1198 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes, Cdx2, Gata2, Irx3</italic>
###xml 1306 1330 1306 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2, Nanog, Klf4, Zfp42</italic>
Although several methods to analyze time course microarray data have been reported (e.g. clustering [12,13], splines [14,15]), we decided to characterize the pattern of gene expression in a simpler way by 2 major parameters: the time of response when it exceeded 1.5-fold change threshold, and the magnitude of response measured by the maximum logratio of expression change (Fig. 2C, Additional file 4) (see Materials and methods for details). The scatterplot of magnitude of response versus time of response for all genes with statistically significant change of expression (FDR <= 0.05, fold change >= 1.5) shows the global picture of gene expression change after manipulation of the Pou5f1 (Fig. 2A). The initial response to Pou5f1 suppression (< 24 hr) is characterized mostly by down-regulation of many genes. It is followed by the wave of gene up-regulation which becomes more intense after 36 hr. Genes with a strongest response had a tendency to be activated or suppressed earlier than genes with a weaker response. Earliest effects were suppression of TFs Foxd3, Mybl2, Zic3, Klf2, and Nr0b1. Later but still within 12 hr we observed activation of TFs that are expressed in trophectoderm (Eomes, Cdx2, Gata2, Irx3). Interestingly, genes that are considered important for pluripotency in ES cells (Sox2, Nanog, Klf4, Zfp42) responded with a considerable delay (> 24 hr).
###end p 16
###begin p 17
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene expression responses to the suppression of <italic>Pou5f1 </italic>(A) or <italic>Sox2 </italic>(B) expression in ES cells.</bold>
Gene expression responses to the suppression of Pou5f1 (A) or Sox2 (B) expression in ES cells. Time and magnitude of responses were estimated from the time course microarray data using 1.5-fold expression changes as a threshold (C), and then used as coordinates in a scatter-plot. Tentative target genes were identified as shown in Fig 1.
###end p 17
###begin p 18
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
Gene expression profiling of ES cells after suppression of Sox2 was carried out using the same protocol (Tet-inducible transgene cell line 2TS22C; the same array platform) as the experiment on Pou5f1 [16]. Thus, results on Sox2 (Fig. 2B, Additional file 6) were fully compatible with that for Pou5f1 experiment.
###end p 18
###begin p 19
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 193 198 193 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, B</xref>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfp42</italic>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nr0b1</italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tcl1</italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dppa3</italic>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 609 615 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Jarid2</italic>
###xml 686 690 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esx1</italic>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gata2</italic>
###xml 699 704 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gata6</italic>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hoxa1</italic>
###xml 718 722 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msx2</italic>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plat</italic>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 875 882 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
The proportion of genes that responded to the suppression of Pou5f1 and Sox2 increased in a similar manner over time (Fig 3A), and the proportion of common genes also increased with time (Fig. 3A, B). Principal Component Analysis (PCA) showed that gene expression response to Pou5f1 and Sox2 suppression was similar when projected on the first principal component (PC1) (Fig 3C). PC1 seems to represent a transition of ES cells from a pluripotent state to more differentiated states because it is associated with a decreased expression of ES cell specific genes (e.g., Nanog, Zfp42, Nr0b1, Tcl1, Dppa3, Klf4, Jarid2), and increased expression of genes related to differentiation (e.g., Esx1, Gata2, Gata6, H19, Hoxa1, Msx2, Plat, keratins). The second principal component (PC2) represented minor fraction of genes that responded differentially to the suppression of Sox2 and Pou5f1 (Fig. 3D).
###end p 19
###begin p 20
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of gene expression responses to suppression of <italic>Pou5f1 </italic>and <italic>Sox2</italic>:</bold>
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
Comparison of gene expression responses to suppression of Pou5f1 and Sox2: (A) number of genes with > 2 fold change in gene expression after suppression of Pou5f1 and Sox2; (B) proportion of genes with consistent responses (i.e., common genes whose expression changed in the same direction) and inconsistent responses (i.e., common genes whose expression changed in the opposite direction) to Pou5f1 and Sox2 suppression among the combined list of genes that responded by > 2 fold to either of these transcription factors; (C-D) Principal Component Analysis (PCA) of gene expression response to the suppression of Pou5f1 and Sox2 based on combined data.
###end p 20
###begin p 21
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 396 403 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 611 612 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 950 951 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 1058 1064 1058 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1188 1194 1188 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1238 1245 1238 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1249 1253 1249 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
We did not have (Tet)-inducible Nanog ES cells, and thus had to use the following three experimental results: (i) time course (1 to 7 days) of shRNA-mediated knockdown in ES cells [5], (ii) shRNA-mediated knockdown of Nanog in ES cells [1], and (iii) stable over-expression of Nanog performed in our laboratory (see Materials and methods). The first data set was analyzed in a way similar to the Pou5f1 data set; however because the experiment was done without replications we combined data points (data from day 3 and 4, and data from day 5, 6, and 7) as replications for statistical analysis (Additional file 7). Combined data points showed similar gene expression profiles based on Principal Component Analysis (PCA) (data not shown). In the latter 2 data sets, we classified genes only based on expression change (positive vs. negative, and > 2 fold change vs. < 2 fold change), and used these classes for estimating the FDR (Additional files 8, 9). When we combined these 3 data sets, the direction of gene response was inverted for the experiment with Nanog over-expression to make it compatible with other data, and genes showing contradictory change were ignored. Because data on Nanog was obtained with different methods than on Pou5f1 and Sox2, it should be interpreted with caution.
###end p 21
###begin p 22
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
It is important to note that genes affected by the alterations of Pou5f1, Sox2, and Nanog expression contain not only primary (direct) targets of these TFs, but also secondary/tertiary targets as shown previously [2].
###end p 22
###begin title 23
2. Data set of genome-wide Chromatin IP
###end title 23
###begin p 24
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 740 741 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 952 953 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 972 974 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S10">10</xref>
###xml 1046 1047 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1201 1202 1199 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1203 1205 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1224 1225 1222 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 1477 1478 1475 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 1825 1826 1821 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 747 752 <span type="species:ncbi:10090">mouse</span>
We used genome-wide ChIP data of POU5F1 and NANOG, published by Loh et al. [1]. All raw data were remapped to the mouse genome sequences and analyzed with the genome annotation using components of CisView software, which includes information on the transcription start sites (TSSs) [17]. As we pointed out in our previous work [2], some known POU5F1 target genes were missed in the POU5F1-target gene list assembled by Loh et al. [1] partly due to the use of a stringent criteria (i.e., >/= 4 ditags). We therefore decided to use both POU5F1 and NANOG ChIP data, when we searched for POU5F1 target or NANOG target. Significant co-localization of POU5F1, SOX2, and NANOG binding sites have been clearly shown recently by ChIP-chip analysis [6]. In mouse, the strength of NANOG binding (measured by the number of ChIP-PET ditags) was positively associated with the strength of POU5F1 binding to the same region according to our re-analysis of ChIP data [1] (Additional file 10). Our analysis of TF binding motifs in DNA regions identified by ChIP [1] showed that ChIP-NANOG regions (isolated with NANOG antibody) had a high abundance of OCT-SOX composite binding motifs also known as HMG/POU cassettes [9,10] (Additional file 7). This finding also confirms co-localization of POU5F1, SOX2, and NANOG binding sites. Moreover, ChIP-NANOG regions that did not overlap with any ChIP-POU5F1 regions also had an increased abundance of OCT-SOX composite binding motifs (Additional file 7). This indicates that NANOG binding can be used as additional evidence of POU5F1 and SOX2 binding and vise versa. Therefore, it is reasonable to use a combination of POU5F1 and NANOG ChIP data for finding POU5F1 targets. For example, in the original ChIP-PET analysis by Loh et al., only binding sites with >/= 4 ditags were considered reliable [1]. In contrast, in our modified approach we could utilize POU5F1 binding sites with only 2 or 3 ditags on condition that they had additional NANOG ditags. This approach increases the sensitivity of finding TF binding sites, but it may have a down side of possibly being too inclusive.
###end p 24
###begin p 25
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
We also used genome-wide ChIP data for SOX2 obtained from human ES cells [18]. However, the human ChIP data were analyzed separately and used only to provide additional gene list for SOX2 targets (see the section 5 below for the details).
###end p 25
###begin title 26
3. Evaluating the ChIP-binding sites with a score of potential function (SPF)
###end title 26
###begin p 27
Presence of a ChIP-binding site of a TF in the promoter of a gene is not yet an evidence of transcription regulation because TF binding may be related to other cellular functions or may be not functional at all. To evaluate the potential functionality of POU5F1 binding sites in transcription regulation we developed a score of potential function (SPF), which was estimated using an ad hoc equation:
###end p 27
###begin p 28

###end p 28
###begin p 29
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 209 211 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 409 416 409 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 494 501 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 720 727 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 790 796 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 857 859 857 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 884 886 884 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 960 967 960 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S11">11</xref>
###xml 1289 1291 1289 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S11">11</xref>
###xml 1375 1377 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1457 1464 1457 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1524 1526 1524 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1580 1581 1580 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1882 1884 1882 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2075 2077 2075 2077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S12">12</xref>
###xml 2201 2203 2201 2203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 2231 2233 2231 2233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S12">12</xref>
###xml 2330 2332 2330 2332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S13">13</xref>
###xml 2337 2339 2337 2339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S14">14</xref>
where N1 and N2 are the number of ChIP-PET ditags for POU5F1 and NANOG (data from [1]), respectively, D is the distance from binding region to TSS, X = 1 for CpG-rich regions and 0 otherwise, and a, b, c, and d are adjustable parameters. As we discussed above, we used data on NANOG binding so that it can provide additional evidence of binding site function. Expression levels of Nanog changed > 48 hr after Pou5f1 suppression; thus, the training sets did not contain genes which responded to Pou5f1 suppression indirectly via the effect of Nanog, and the use of NANOG binding could not affect SPF in favor of indirect effects. The SPF was optimized to best separate between the training set of genes that responded to Pou5f1 suppression and control set of genes that were not affected by Pou5f1. We used 2 training sets of genes that were down-regulated (N = 782) and up-regulated (N = 519), respectively, by at least 2 fold and responded non-transiently to Pou5f1 suppression within the time window from 6 to 48 hr (Additional file 11). Genes that responded earlier than 6 hr may have been affected by other factors besides the gradually decreasing amount of POU5F1 protein, and genes that responded later than 48 hr are more likely to be affected indirectly. The control set of genes (N = 3048, Additional file 11) contained genes with medium- or high-quality promoters [17] represented by a responsive oligo in the microarray, which did not respond to Pou5f1 and had no differential expression between ES and TS cells [19]. Adjustable parameters were changed to maximize the t-statistics for the difference in average SPF values between the training and control set of genes (see Methods for details). To avoid circular reference by estimating SPF for genes in the training and control set with parameters optimized for the same genes, we used the bootstrap resampling method [20]. Scores for POU5F1 binding sites were positively affected by the number of ChIP ditags and negatively affected by the distance from TSS and by CpG richness of the sequence (Additional file 12). Down-regulated genes were more widely separated from control genes by their average SPF than up-regulated genes based on t statistics (Additional file 12). Characteristics of binding sites with highest SPF for each gene are given in Additional files 13 and 14.
###end p 29
###begin title 30
4. Identification of Tentative Target Genes (TTGs) for POU5F1
###end title 30
###begin p 31
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 808 809 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 808 809 808 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 810 811 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 818 819 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 823 825 823 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b&#183;x </italic>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S15">15</xref>
###xml 899 900 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
We developed a novel algorithm to identify direct targets of a TF by first separating genes that responded to TF-manipulation into groups according to their expression patterns: direction (up-regulation vs. down-regulation), magnitude (> 2 fold vs. < 2 fold change) and time (in 12 hr intervals) of response. We then applied the FDR criterion to each group individually (Fig. 1). Genes with transient response were handled separately from genes with constitutive response. FDR was estimated in two steps: first p-values were estimated for each gene on the basis of the SPF of a binding site in the promoter and cumulative probability distribution of SPF for binding sites in promoters of control genes. The probability distribution of SPF in the control set of genes was approximated by a linear function loge(p|SPF > x) = a + b.x (Additional file 15), and then the regression was used to calculate p-values. FDR was then calculated in each group of genes as described [21]. Numerical examples showing the advantage of this approach are given in the Methods section.
###end p 31
###begin p 32
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfp42</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esrrb</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Utf1</italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lefty1</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Otx2</italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spp1</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upp1</italic>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fbxo15</italic>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dppa5</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdyl</italic>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2</italic>
###xml 607 614 605 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 659 663 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf4</italic>
###xml 806 808 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S16">16</xref>
###xml 998 1004 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
Assuming that we can tolerate up to 20% of false positives, we set FDR threshold to 0.2 and identified 420 TTGs of POU5F1 (Fig 2A, Additional file 4). The list of genes included the majority of known POU5F1 targets (Sox2, Nanog, Zfp42, Klf4, Esrrb, Utf1, Lefty1, Otx2, Spp1, Upp1, Fbxo15, Dppa5, Cdyl, Cdx2), which supports the validity of our analysis. Although one-fifths of these TTGs are in theory false positives due to FDR </= 0.2, we believe that this is the best result we can obtain with the current technology and uniform data analysis applied to all the genes. Some genes with strong response to Pou5f1 were not included in the list of TTGs (e.g., Fgf4), because the FDR values were slightly above the accepted threshold. We, therefore, assembled an additional list of 65 genes (Additional file 16) that are likely to be targets of POU5F1 although they did not pass our statistical criteria. These genes had either relatively low FDR values or additional evidence of their regulation by Pou5f1.
###end p 32
###begin p 33
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S17">17</xref>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 697 704 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S18">18</xref>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
A list of target genes identified in this paper matched reasonably with lists of genes identified in earlier studies. Of 420 TTGs identified for Pou5f1, 82 genes overlapped with a list of genes identified in Matoba et al. [2], and 125 genes overlapped with a list of genes identified in Loh et al. [1] (Additional file 17). TTGs that were identified in earlier studies, but not identified in the current study fell into two categories: (i) TTGs that had weak binding sites; and (ii) TTGs that did not respond significantly to Pou5f1 manipulation in our experiment, as judged by the distribution of a simple score estimated as a product of SPF and absolute magnitude of gene expression response to Pou5f1 suppression (Additional file 18). The scores for TTGs identified in this paper were substantially higher than those for non-matching genes from the earlier papers, indicating that the current list of TTGs was high quality. Furthermore, there was significant overlap between TTGs identified in the current work and TTGs identified in the previous meta-analysis of gene expression in ES cells [22]: out of 83 genes with current gene symbols, 33 genes were identified as TTGs of POU5F1 in the current work.
###end p 33
###begin p 34
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 198 205 198 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S16">16</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S19">19</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 711 718 711 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 874 875 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Suz12 </italic>
###xml 925 929 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phc1</italic>
###xml 1009 1011 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1101 1106 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4 </italic>
###xml 1145 1149 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1155 1159 1155 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HDC </italic>
###xml 1160 1163 1160 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdc</italic>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1175 1179 1175 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp1 </italic>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1194 1199 1194 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4 </italic>
###xml 1243 1250 1243 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lefty1 </italic>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1293 1300 1293 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1307 1312 1307 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfp57</italic>
###xml 1314 1319 1314 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfp74</italic>
###xml 1321 1327 1321 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfp459</italic>
###xml 1416 1418 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1505 1507 1505 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1523 1530 1523 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt3b </italic>
###xml 1680 1682 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1685 1690 1685 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdyl </italic>
###xml 1767 1769 1767 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1797 1801 1797 1801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JmjC</italic>
###xml 1870 1872 1870 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1918 1921 1918 1921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id1</italic>
###xml 1923 1926 1923 1926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id3</italic>
###xml 1928 1931 1928 1931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id4</italic>
###xml 2021 2022 2021 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 2102 2108 2102 2108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp27</italic>
###xml 2110 2116 2110 2116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp12</italic>
###xml 2118 2124 2118 2124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inpp5d</italic>
###xml 2160 2165 2160 2165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Smad7</italic>
###xml 2182 2187 2182 2187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sfrp1</italic>
###xml 2207 2213 2207 2213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igfbp2</italic>
###xml 2256 2262 2256 2262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Htra1 </italic>
###xml 2326 2328 2326 2328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2365 2371 2365 2371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ubqln4</italic>
###xml 2373 2377 2373 2377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ubl3</italic>
###xml 2379 2384 2379 2384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ubxd4</italic>
###xml 2386 2391 2386 2391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Usp28</italic>
###xml 2479 2485 2479 2485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
Interestingly, we found that Pou5f1 functions mostly as a positive regulator of target gene expression in ES cells: among 420 TTGs of POU5F1, the majority (N = 372; 88.6%) were down-regulated after Pou5f1 suppression and only 48 TTGs were up-regulated (Fig. 2A). This was a surprise, because Pou5f1 is thought to suppress the expression of genes associated with cell differentiation. To address this issue, we analyzed 420 POU5F1-TTGs and 65 additional TTGs (from Additional file 16) based on Gene Ontology (GO) terms (Additional file 19) and literature (PubMed) and found 4 major categories for positive regulation and 1 category for negative regulation (Fig. 4). One notable category among genes activated by Pou5f1 was the "suppressors of cell differentiation," which was comprised of many known and hypothetical transcriptional repressors and signaling repressors (Fig. 4). These include polycomb genes such as Suz12 and Phc1, which are known to repress genes associated with differentiation in ES cells [23]. Zinc finger TFs are also known as suppressors of gene expression [24,25]. For example, Klf4 directly suppresses the expressions of p53 [26], HDC (Hdc) [27], and Sp1 [28], although Klf4 also activates a number of genes, including Lefty1 [29]. Some of zinc finger TFs activated by Pou5f1 (e.g., Zfp57, Zfp74, Zfp459) have KRAB domains, which are involved in gene-silencing and heterochromatin formation [30]. Some chromatin remodeling proteins are also known for suppressing gene expressions [31]. For example, Dnmt3b is a de novo DNA methyltransferase which can contribute to transcription silencing, although the gene seems dispensable for pluripotency maintenance [32]. Cdyl is a transcriptional co-repressor which is active via its CoA-pocket domain [33]. TFs with Jumonji domain (JmjC) function as histone demethylase and modulate the chromatin status [34]. Inhibitors of helix-loop-helix TF binding (Id1, Id3, Id4) are also included in the list. The "suppression of cell differentiation" category (Fig. 4) also includes a number of inhibitors of cell signaling, such as phosphatases (Dusp27, Dusp12, Inpp5d), inhibitors of TGFbeta signaling (Smad7), WNT inhibitor Sfrp1, and IGF inhibitor Igfbp2. Proteases are also included in the list: Htra1 inactivates TGFbeta signaling possibly via modification of ECM [35]; and ubiquitination-related genes (Ubqln4, Ubl3, Ubxd4, Usp28) may suppress gene activity via degradation of transcription-activation complexes. The Pou5f1, thus, seems to suppress the expression of genes associated with cell differentiation by positively regulating the "suppressors of cell differentiation."
###end p 34
###begin p 35
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Major functional groups of tentative target genes (TTGs) of POU5F1.</bold>
Major functional groups of tentative target genes (TTGs) of POU5F1. Genes in blue: genes that passed the criterion for TTGs (FDR < 0.2). Genes in red: additional genes that did not pass this criterion but are still likely to be targets.
###end p 35
###begin p 36
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxd3 </italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sall4</italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 404 411 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 494 500 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dppa3 </italic>
###xml 501 513 501 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stella, Pgc7</italic>
###xml 649 652 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mif</italic>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mybl2</italic>
###xml 661 664 661 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc</italic>
###xml 666 670 666 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycn</italic>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 781 787 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mybl2 </italic>
###xml 788 799 788 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b-Myb, Bmyb</italic>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myc </italic>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1003 1008 1003 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tcl1 </italic>
###xml 1047 1048 1047 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1243 1249 1243 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 1261 1268 1261 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1408 1414 1408 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
Other groups of TTGs activated directly by POU5F1 are "major pluripotency-related genes", "genes associated with cell proliferation", and "genes associated with morphogenesis" (Fig. 4). The first group includes mostly known targets of POU5F1. Pluripotency-related genes, Foxd3 and Sall4, which are known for Nanog dependency [2,36], were also TTGs of POU5F1, because in our experiments they responded to Pou5f1 suppression long before the change of expression of Nanog. Germ line specific gene Dppa3 (Stella, Pgc7) was another new TTG of POU5F1. The group of "genes associated with cell proliferation" included major regulators of cell cycle (e.g., Mif, Mybl2, Myc, Mycn), DNA metabolism/repair genes, growth factors, and others, which are consistent with the earlier report [31]. Mybl2 (b-Myb, Bmyb) and Myc promote cell transition from G1 phase to S phase, and therefore contribute to the unique cell cycle structure (long S phase [37]) in ES cells [38,39]. The regulation of ES cell proliferation by Tcl1 has also been demonstrated previously [2]. Surprisingly, the group of "genes associated with morphogenesis", which included many embryonic growth factors, receptors, TFs, and signal transduction genes, appeared positively regulated by Pou5f1. Possibly, Pou5f1 is not the only transcription regulator of these genes because many of them remain active in developing embryo even after full silencing of Pou5f1.
###end p 36
###begin p 37
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2 </italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes</italic>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 218 223 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2 </italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrb1</italic>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2</italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cidea</italic>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes</italic>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf5</italic>
###xml 658 666 658 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45g </italic>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
In contrast, a small number of TTGs labeled as "differentiation-related genes" (e.g., Cdx2 and Eomes), was negatively regulated by Pou5f1. It has been shown that POU5F1 can block the transcriptional auto-activation of Cdx2 by CDX2 protein [36]. Although these genes have POU5F1 binding sites identified by ChIP, the functionality of these sites as transcription repressors has not been confirmed experimentally. If these binding sites are indeed involved in repression of transcription, then this mechanism may complement other more generic mechanisms of repression of genes associated with differentiation. For example, Arrb1, Cdx2, Cidea, Eomes, Fgf5, and Gadd45g have bivalent chromatin domains (carrying both activating H3K4 tri-methylation and repressing H3K27 tri-methylation) [40], and thus can be repressed via polycomb genes.
###end p 37
###begin p 38
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
Thus, the main function of POU5F1 binding to promoters is activation of target genes, whereas suppression of genes related to cell differentiation is mostly indirect and mediated by specialized gene silencing mechanisms, many components of which are activated directly by Pou5f1. The Pou5f1 may have additional molecular functions besides direct regulation of transcription (e.g., inactivation of CDX2 protein via direct binding with POU5F1 protein in heterochromatin [36]); however these effects are beyond the scope of this paper. POU5F1 can interact directly with transcriptional repression complexes in ES cells [41], but it is not clear to what extent this interaction involves sequence-specific binding of POU5F1 to DNA.
###end p 38
###begin title 39
5. Identification of target genes for SOX2 and NANOG
###end title 39
###begin p 40
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S20">20</xref>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 460 466 460 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S21">21</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Target genes for SOX2 and NANOG were identified using the same strategy as for POU5F1 (Fig. 1). Data sources used for this analysis are summarized in Additional file 1. Many TTGs of SOX2 and NANOG overlapped with TTGs of POU5F1 (Additional file 20). Similarly to Pou5f1, Sox2 and Nanog seem to function as activators of gene expression rather than repressors: 222 genes (99.1%) were activated by Sox2 (out of 224 TTGs), and 251 genes (81.0%) were activated by Nanog (out of 310 TTGs) (Additional file 21; This table does not include genes that are regulated indirectly or via protein-protein interaction, e.g. by inactivation of SMAD1 by NANOG [42]).
###end p 40
###begin p 41
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S22">22</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 662 667 <span type="species:ncbi:9606">human</span>
###xml 672 677 <span type="species:ncbi:10090">mouse</span>
We also assembled a table of additional TTGs of SOX2 based on human ES cell data, because ChIP data for SOX2 in mouse ES cells are not available and we might have missed important genes. We used ChIP data for SOX2 in human ES cells [6] and microarray data in mouse ES cells after Sox2 suppression (> 2 fold change of gene expressions) [16]. A list of genes is available in Additional file 22 for readers who are interested in these additional genes, but these genes were not used for further analyses described below. A gene list may contain a proportion of false positives larger than 20%, because the target genes of these TFs do not necessary overlap between human and mouse ES cells [43,1].
###end p 41
###begin title 42
6. Common target genes of POU5F1, SOX2, and NANOG
###end title 42
###begin p 43
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S21">21</xref>
###xml 561 567 561 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 589 591 589 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 633 635 633 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 680 682 680 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 160 165 <span type="species:ncbi:9606">human</span>
It has been shown that POU5F1, SOX2, and NANOG proteins co-occupy promoters of a substantial portion of their target genes in the analysis of ChIP-Chip data of human ES cells [6]. Consistent with this notion, new lists of TTGs identified in this paper based on both ChIP data and expression profiling data showed that out of 700 combined TTGs of POU5F1, SOX2, and NANOG, only 209 genes (29.9%) were affected by one of these TFs; other TTGs were affected by 2 or 3 TFs (Fig. 5A, Additional file 21). The majority of TTGs were down-regulated after suppression of Pou5f1, Sox2, and/or Nanog (N = 512, 73.1%), very few were upregulated (N = 74, 10.6%), and some had a mixed response (N = 114, 16.3%) (Fig. 5A).
###end p 43
###begin p 44
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of tentative target genes (TTGs) responding to the suppression of <italic>Pou5f1</italic>, <italic>Sox2</italic>, or <italic>Nanog</italic>.</bold>
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 455 462 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 518 525 518 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 568 569 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 570 571 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 571 572 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 581 583 581 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 588 590 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 612 619 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 690 691 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 691 693 691 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 696 697 696 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 706 708 706 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 713 715 713 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 755 762 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 863 868 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 979 986 979 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1006 1011 1006 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 1079 1086 1079 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1090 1096 1090 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1105 1112 1105 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1143 1150 1143 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
Comparison of tentative target genes (TTGs) responding to the suppression of Pou5f1, Sox2, or Nanog. (A) Venn diagram of combined TTGs of POU5F1, SOX2, and NANOG. Number of genes that were up-regulated (magenta), down-regulated (blue), or had a mixed response (gray) to the suppression of Pou5f1, Sox2, and Nanog. (B) The same Venn diagram as (A) after removing genes with possible indirect effects. (C) Comparison of gene responses to the suppression of Pou5f1 and Sox2 (TTGs of POU5F1 that were down-regulated after Pou5f1 suppression): response time ratio = log10(t2/t1) where t1 and t2 are response times to Pou5f1 and Sox2 suppression, respectively; difference of response magnitude = m2 - m1, where m1 and m2 are response magnitudes (log-ratios) to Pou5f1 and Sox2 suppression, respectively; genes in the blue quadrant responded more strongly and faster to Sox2 suppression than to Pou5f1 suppression, and genes in the yellow quadrant responded more strongly and faster to Pou5f1 suppression than to Sox2 suppression. (D) Comparison of gene responses to the suppression of Pou5f1 and Nanog (TTGs of Pou5f1 that were down-regulated after Pou5f1 suppression); notations are the same as in (C).
###end p 44
###begin p 45
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 516 522 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 534 540 534 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 793 799 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 801 805 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 811 817 811 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
One of the concerns was that these common TTGs could have been erroneously identified, because Pou5f1, Sox2, and Nanog affect the expression of each other and thereby indirectly affects downstream gene expressions. To eliminate possible indirect effects, we used our observation that manipulation of each of these 3 genes changed the expression of other genes with a substantial delay (> 34 hr), which makes it possible to separate gene networks affected by each TF. We plotted another Venn diagram where effects of Pou5f1, Sox2, and Nanog were counted only if target genes responded before the response time of other members within this group of 3 major TFs associated with ES cell pluripotency (Fig. 5B). Even after removal of these possible indirect effects, correlation between effects of Pou5f1, Sox2, and Nanog remained strong.
###end p 45
###begin p 46
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 145 147 145 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 363 365 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 504 510 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 654 661 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 665 671 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 672 674 672 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 775 777 775 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 826 831 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 835 841 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 956 958 956 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 977 984 977 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 988 993 988 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 1108 1115 1108 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1119 1124 1119 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 1125 1127 1125 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1199 1201 1199 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1229 1231 1229 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1284 1291 1284 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45g</italic>
###xml 1314 1318 1314 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf5</italic>
###xml 1320 1325 1320 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgfr2</italic>
###xml 1336 1342 1336 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes </italic>
###xml 1346 1351 1346 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dmrt1</italic>
We also examined a possibility that these co-regulations occurred by chance. For example, the number of genes activated by both Pou5f1 and Sox2 (N = 137, Fig. 5B) was significantly higher than expected from permutation of 1729 genes with strong binding sites (with SPF > 95-percentile in control genes); expected overlap was only 43.61 genes (chi-square = 50.95, p < 0.001). Permutation was limited to genes with strong binding sites to avoid the possibility that apparent correlation between effects of Pou5f1, Sox2, and Nanog simply resulted from the use of the same ChIP dataset for selecting TTGs for these TFs. The number of genes activated by both Pou5f1 and Nanog (N = 63) was also significantly higher than expected from permutation (31.96 genes; chi-square = 10.43, p = 0.001). In contrast, co-activation of genes by Sox2 and Nanog appeared non-significant: only 31 genes were activated by both TFs versus expected 17.99 genes (chi-square = 3.51, p = 0.06). Effect of Pou5f1 and Sox2 was similar not only in activation but also in suppression of target genes. The number of genes suppressed by both Pou5f1 and Sox2 (N = 14) was statistically higher than expected from permutation (expected N = 1.23, chi-square = 10.75, p = 0.001). These genes included cell-cycle suppressor Gadd45g, FGF-signaling genes (Fgf5, Fgfr2), and TFs Eomes and Dmrt1.
###end p 46
###begin p 47
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 355 362 355 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 594 600 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 715 722 715 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 725 730 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S21">21</xref>
###xml 953 960 953 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 961 963 961 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 973 979 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 980 982 980 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1070 1077 1070 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1078 1080 1078 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1089 1095 1089 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1096 1098 1096 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1185 1192 1185 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1196 1201 1196 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 1229 1231 1229 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1283 1285 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S21">21</xref>
###xml 252 257 <span type="species:ncbi:10090">mouse</span>
Expression of TTGs of POU5F1, SOX2, and NANOG may be regulated by other factors as well. To distinguish genes that are predominantly regulated by Pou5f1 and Nanog, we analyzed the expression of TTGs in lineage committed cell types reported previously: mouse trophoblast stem cells (TS), neural stem cells (NS), and embryonic fibroblasts (MEF) [44,45,19]. Pou5f1 and Nanog are not expressed in these cell types. However, Sox2 is expressed in NS and TS (lower expression levels than in ES cells), but is not expressed in MEF. We expected that genes that are predominantly regulated by Pou5f1 and Nanog will change their expressions in these cell types in the same direction as in the ES with suppressed expression of Pou5f1 or Nanog. Out of 700 TTGs, 383 were consistently down-regulated and 94 were consistently up-regulated in lineage-committed cells (Additional file 21). In the former group 92.7% genes were down-regulated after suppression of either Pou5f1 (N = 324) or Nanog (N = 159), and in the latter group only 42.6% genes were up-regulated after suppression of Pou5f1 (N = 33) or Nanog (N = 18). In total, we found 395 TTGs that were expected to be predominantly regulated by Pou5f1 and Nanog, and the majority of them (N = 355) were activated by these TFs (Additional file 21).
###end p 47
###begin title 48
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
7. Differential effects of Pou5f1, Sox2 and Nanog on their TTGs
###end title 48
###begin p 49
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 525 532 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 627 632 627 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 652 659 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 834 841 834 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
Although Pou5f1, Sox2, and Nanog cooperate strongly in their effects on target genes, their roles may not be equal. For example, Sox2 is dispensable in activation of several known gene expression enhancers with OCT-SOX composite binding site [16]. Thus, we wanted to check if the same was true for other genes activated by Pou5f1. Among 378 TTGs of POU5F1 that were down-regulated after Pou5f1 suppression, 131 were not affected by Sox2 suppression, and 148 responded more weakly and with delay compared to their response to Pou5f1 suppression (Fig. 5C, upper right quadrant). Some genes from the latter set may be affected by Sox2 only indirectly via Pou5f1 suppression; however testing this hypothesis would require further study. Only 12 genes responded to Sox2 suppression more strongly and faster compared with their response to Pou5f1 suppression (Fig. 5C, lower left quadrant).
###end p 49
###begin p 50
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 298 304 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 376 382 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 415 422 415 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 530 536 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 637 644 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 753 759 753 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 783 790 783 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 803 805 803 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bmp4</italic>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spred2</italic>
###xml 888 893 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry4</italic>
###xml 895 901 895 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igfbp2</italic>
###xml 919 925 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 937 943 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 976 983 976 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1033 1038 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 1042 1048 1042 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 1192 1198 1192 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1206 1212 1206 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
Similarly, out of 378 TTGs of POU5F1 that were down-regulated after Pou5f1 suppression, 237 were not affected by Nanog, and 33 responded to Nanog suppression weaker and with delay compared to their response to Pou5f1 suppression (Fig. 5D, upper right quadrant). Small number of genes responding to Nanog manipulation can be partially explained by the fact that suppression of Nanog did not change the expression of Pou5f1 in both knockdown and overexpression experiments, and therefore, there were no indirect effects mediated by Pou5f1. Only 5 genes responded to Nanog suppression more strongly and faster compared to their response to Pou5f1 suppression (Fig. 5D, lower left quadrant). Genes that responded more strongly (but not necessary faster) to Nanog suppression compared to Pou5f1 suppression (N = 13) were enriched in genes associated with growth factor activity (Bmp4, Spred2, Spry4, Igfbp2). Thus, although Pou5f1, Sox2, and Nanog cooperate in activation of TTGs, Pou5f1 plays the major role in this cooperation, whereas Sox2 and Nanog generally have a weaker effect. However, there were exceptions from this general rule because some genes were affected more strongly by Sox2 or Nanog than by Pou5f1.
###end p 50
###begin p 51
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt3b</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxd3</italic>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id4</italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Jmjd2c</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Suz12</italic>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esrrb</italic>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sfrp1</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tdgf1</italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfp42</italic>
###xml 339 346 339 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 412 425 412 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dppa5 (Esg1) </italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Utf1</italic>
###xml 460 466 460 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 485 491 485 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dppa3 </italic>
###xml 492 498 492 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stella</italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dazl </italic>
###xml 527 534 527 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dppa3</italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dazl</italic>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 627 632 627 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2 </italic>
###xml 650 657 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 705 711 705 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes </italic>
###xml 729 736 729 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lefty1 </italic>
###xml 811 816 811 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nodal</italic>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 846 852 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 869 875 869 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 900 906 900 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 918 924 918 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
Examples of differential effects of Pou5f1, Sox2, or Nanog on their TTGs are given in Fig. 6. Many suppressors of cell differentiation (e.g., Dnmt3b, Foxd3, Id4, Jmjd2c, and Suz12) were activated by Pou5f1 and Sox2 but not by Nanog, whereas several genes associated with ES cell pluripotency (Esrrb, Sfrp1, Tdgf1, Zfp42) were activated by Pou5f1 and Nanog but not by Sox2. Some pluripotency-related genes (e.g., Dppa5 (Esg1) and Utf1) were activated solely by Pou5f1. Germline markers Dppa3 (Stella) and Dazl were activated by Pou5f1 and Sox2 but either suppressed (Dppa3) or not affected (Dazl) by Nanog. Trophectoderm marker Cdx2 was suppressed by Pou5f1 and Nanog, whereas another trophectoderm marker Eomes was suppressed by Pou5f1 and Sox2 but not by Nanog. Genes associated with morphogenesis, Lefty1 and Nodal, were suppressed by Sox2 and Nanog but activated by Pou5f1. Differential effect of Pou5f1, Sox2, and Nanog on target genes may be important for embryo patterning and regulation of metabolism.
###end p 51
###begin p 52
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
Examples of tentative target genes responding differentially to the suppression of Pou5f1, Sox2, and Nanog.
###end p 52
###begin p 53
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S21">21</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dab1</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fut9</italic>
###xml 319 325 319 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrp2</italic>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gbx2</italic>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nef</italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zic2</italic>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zic5</italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdh2</italic>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dpysl3</italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fez1</italic>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lrrn1</italic>
###xml 644 650 644 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdzrn4</italic>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sema6a</italic>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Timp4</italic>
###xml 667 670 667 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vim</italic>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zic1</italic>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S22">22</xref>
###xml 755 760 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
Some differential effects were observed on quantitative level only. For example, TTGs of Sox2 that were down-regulated more strongly (but not necessary faster) after Sox2 suppression compared to Pou5f1 suppression (N = 100, Additional file 21) were enriched in genes associated with neural differentiation (Dab1, Fut9, Notch1, Nrp2, Pax6, Gbx2, Nef, Zic2, Zic5), and first 5 of these genes were over-expressed in NS compared to ES, according to published data [45,44]. Interestingly, additional TTGs of SOX2 that had no POU5F1 or NANOG binding sites, were also enriched in genes that were over-expressed in NS (e.g., Cdh2, Dpysl3, Fez1, Lrrn1, Pdzrn4, Sema6a, Timp4, Vim, Zic1) (Additional file 22). These observations are consistent with a known role of Sox2 in neural differentiation [46,47].
###end p 53
###begin title 54
Conclusion
###end title 54
###begin p 55
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 539 545 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 949 955 949 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 957 961 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
We have developed a novel algorithm to evaluate the statistical significance of direct downstream target genes for a TF. The method uses two data inputs: genome-wide time-course expression profiling data after the manipulation of TF expression level; and genome-wide ChIP data. We have applied this method to key pluripotency genes - Pou5f1, Sox2, and Nanog, and identified their TTGs in ES cells. Because the majority of TTGs were activated and only a few of them were suppressed, we conclude for the first time that the main function of Pou5f1, Sox2, and Nanog when they are bound to promoters is activation of gene expression rather than suppression. Thus, the role of these TFs in suppression of genes associated with differentiation is mostly indirect and is mediated via specialized gene silencing mechanisms. This idea is supported by our observation that transcription of many components of these silencing pathways is directly activated by Pou5f1, Sox2, and Nanog. These 3 genes may have additional molecular functions that are not related to binding to the promoters of target genes, but these functions cannot be inferred from ChIP data and therefore require different methods of analysis.
###end p 55
###begin title 56
Methods
###end title 56
###begin title 57
Microarray experiments
###end title 57
###begin p 58
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 795 796 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 803 809 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 917 923 916 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1001 1006 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 1366 1372 1365 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1419 1421 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1424 1429 1423 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog</italic>
###xml 1544 1546 1543 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1641 1647 1639 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1798 1804 1792 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1972 1974 1966 1968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 2187 2189 2174 2176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
For microarray experiments we used ZHBTc4 ES cells with a Tet-inducible Pou5f1 transgene [4]. Cells were cultured for 2 passages on gelatin-coated plates in order to remove feeder cells and then transferred to gelatin-coated 6-well plates at the density of 1-2 x 105 cells/well and cultured in complete ES medium: DMEM, 15% FBS; LIF (ESGRO, Chemicon, USA) 1000 U/ml; 1 mM sodium pyruvate; 0.1 mM NEAA, 2 mM glutamate, 0.1 mM beta-mercaptoethanol, and penicillin/streptomycin (50 U/50 mug per ml). Tetracycline was added at 24 hr after cell plating, and then cells were harvested at 0 hr (before adding tetracycline), 3 hr, 6 hr, 12 hr, and 24 hr (2 replications each). RNA samples for later time points (24, 48, 72, 96, and 120 hr) were obtained from our earlier experiment with 3 replications [2]. Two Nanog over-expressing clones were tested: integrated and episomal transgene. To generate an integrated transgene, Nanog cDNA was amplified by PCR and cloned into pEF6/pIRESneo3 vector (Invitrogen). Nanog-pEF6/pIRESneo3 construct was transfected into MC1 cell line (129S6/SvEvTac strain; purchased from the Transgenic Core Laboratory of the Johns Hopkins University School of Medicine). After 10 days of selection in 300 ug/ml G418 (Invitrogen), resistant colonies were picked and expanded. To generate an episomal transgene, plasmid construct was made by cloning Nanog cDNA into pPyCAGIP episomal expression vector [48]. Nanog-pPyCAGIP episomal expression construct was transfected into MG1.19 cell line, expressing polyoma T large antigen [49]. After 7 days of puromycin selection, 2 mug/ml, resistant colonies were picked, expanded and Nanog expression level was confirmed by real time PCR: it was 2.14 +/- 0.14 fold for the integrated clone and 19.6 +/- 1.1 fold for the episomal clone. Both Nanog transgenic and parental cell lines were cultured for 2 passages on gelatin-coated plates and then transferred to gelatin-coated 6-well plates at the density of 1-2 x 105 cells/well and cultured for 3 days in 3 different conditions: (1) complete ES medium (see above); (2) complete medium without LIF, and (3) complete medium with 1 muM RA. Cells were cultured at 37degreesC and 5% CO2 condition and the culture medium was changed daily.
###end p 58
###begin p 59
###xml 956 958 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1111 1112 1092 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1204 1206 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 484 489 <span type="species:ncbi:10090">Mouse</span>
###xml 743 748 <span type="species:ncbi:10090">Mouse</span>
###xml 853 858 <span type="species:ncbi:10090">Mouse</span>
###xml 1137 1142 <span type="species:ncbi:10090">Mouse</span>
Total RNAs were extracted using Trizoltrade mark (1 ml/well; Invitrogen, USA) and Phase lock geltrade mark columns (Eppendorf/Brinkman) according to the manufacturer's protocol. Total RNAs were precipitated with isopropanol, washed with 70% ethanol, and dissolved in DEPC-treated H2O. 2.5 mug of total RNA samples were labeled with Cy3-CTP using a Low RNA Input Fluorescent Linear Amplification Kit (Agilent, USA). A reference target (Cy5-CTP-labeled) was prepared from the Universal Mouse Reference (UMR) RNA (Stratagene, USA). Labeled targets were purified using an RNeasy Mini Kit (Qiagen, USA) according to the Agilent's protocol, quantified by a NanoDrop scanning spectrophotometer (NanoDrop Technologies, USA), and hybridized to the NIA Mouse 44 K Microarray v2.1 (whole genome 60-mer oligo; manufactured by Agilent Technologies, #012799) and NIA Mouse 44 K Microarray v2.2 (whole genome 60-mer oligo; manufactured by Agilent Technologies, #014117) [19] according to the Agilent protocol (G4140-90030; Agilent 60-mer oligo microarray processing protocol - SSC Wash, v1.0). RNA samples from experiment of [2] were hybridized to NIA Mouse 22 K Microarray Dev2 (Agilent Technologies, design #012165) [19]. All hybridizations were carried out in the two color protocol by combining one Cy3-CTP-labeled experimental target and Cy5-CTP-labeled reference target. Microarrays were scanned on an Agilent DNA Microarray Scanner, using standard settings, including automatic PMT adjustment.
###end p 59
###begin title 60
Statistical analysis of microarrays
###end title 60
###begin p 61
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1150 1151 1150 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1183 1184 1183 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1185 1187 1185 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 1185 1187 1185 1187 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>t </italic></sub>
###xml 1189 1190 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1190 1192 1190 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 1190 1192 1190 1192 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>t </italic></sub>
###xml 1194 1195 1194 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1195 1198 1195 1198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">24 </sub>
###xml 1200 1201 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1201 1203 1201 1203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">24</sub>
###xml 1211 1212 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1212 1214 1212 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 1212 1214 1212 1214 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>t </italic></sub>
###xml 1218 1219 1218 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1220 1222 1220 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 1220 1222 1220 1222 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>t </italic></sub>
###xml 1312 1313 1312 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1313 1316 1313 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">24 </sub>
###xml 1361 1362 1361 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1369 1370 1369 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1370 1373 1370 1373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">24 </sub>
###xml 1695 1697 1695 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1765 1766 1765 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1784 1789 1784 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2 </italic>
###xml 1827 1829 1827 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S23">23</xref>
###xml 1952 1953 1952 1953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1667 1672 <span type="species:ncbi:10090">Mouse</span>
###xml 1724 1729 <span type="species:ncbi:10090">Mouse</span>
The data discussed in this publication have been deposited in NCBI Gene Expression Omnibus and are accessible through GEO Series accession number (GSE8617). All the microarray data are available at the public GEO website [50,51]. The data and analysis software are also available at the NIA Array Analysis website [52,53]. Because some arrays showed slight reduction of Cy5 signal (UMR) due to ozone bleaching we compensated for this effect as follows. First we selected 100 genes with the highest variances of Cy5 signal and with average log10-signal > 2.5, and estimated the average Cy5 signal for these genes in each array which roughly represented the degree of bleaching effect. Then we used a linear regression to fit Cy5 log signal for each gene as a function of the bleaching effect (average log Cy5 signal of 100 genes described above), and the Cy3 signal in the same array. Then the effect of bleaching was subtracted. If after this correction, log Cy5 signal in array differed by > 3.SD from the mean log Cy5 signal it was replaced by the mean. Data on earlier time points (3-24 hr) was combined with data on later time points (24-120 hr)[2] that was adjusted as follows: x't = xt - x24 + y24, where xt and x't are log gene expression for time point > 24 hr before and after adjustment, respectively, x24 is log gene expression in the experiment of [2], and y24 is log gene expression in the new experiment. For the majority of genes we used the same oligo sequence in both data sets that were combined. However, for some genes that had no common oligo we combined data from different oligos. Data on genes that had no oligo (or no sensitive oligo) in NIA Mouse 22 K Microarray Dev2 (N = 109) were taken from NIA Mouse 22 K Microarray Dev1 presented in [2]. Information on Cdx2 is based on PCR data (Additional file 23) because our microarray probe for this gene was not responsive. Source of data for each gene is listed in Additional file 2.
###end p 61
###begin p 62
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 452 459 450 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 758 760 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1146 1148 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1149 1151 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 961 966 <span type="species:ncbi:10090">Mouse</span>
Statistical analysis was done using the NIA Array Analysis software [52]. To reduce the number of false positives we used the maximum of the actual error variances for a gene and the average error variance estimated from 500 genes with similar signal intensity. Difference in expression was considered significant on the basis of false discovery rate FDR </= 0.05, which accounts for the effect of multiple hypotheses testing. Time of gene response to Pou5f1 suppression was estimated as the time when interpolated gene expression reached the level of 1.5 fold difference compared to the 0 hr initial time point, and the magnitude of response was estimated as the maximum log-ratio of gene expression (either positive or negative) compared to 0 hr (see Fig. 2C). Expression change was considered transient if after reaching its peak (positive or negative), it declined to < 1.5 fold change or became inverted. Gene ontology (GO) analysis was done using the NIA Mouse Gene Index software, which evaluates statistical significance using the hypergeometric probability distribution with parameters: FDR = 0.05, over-representation ratio > 1.5 fold [54-56].
###end p 62
###begin title 63
Identification of tentative target genes (TTGs)
###end title 63
###begin p 64
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S11">11</xref>
###xml 504 511 504 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 907 914 907 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1027 1034 1027 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1135 1142 1135 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1501 1503 1499 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1588 1595 1586 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 1599 1605 1597 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1614 1615 1612 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1735 1737 1733 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1847 1849 1845 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 2324 2331 2322 2329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 2576 2578 2574 2576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 2837 2843 2835 2841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 2973 2975 2971 2973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 3217 3218 3215 3216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3408 3410 3406 3408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 3605 3606 3603 3604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 3608 3609 3606 3607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 3611 3612 3609 3610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 3618 3619 3616 3617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 3710 3711 3708 3709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 3814 3815 3812 3813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 3932 3933 3930 3931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3993 3995 3991 3993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1692 1697 <span type="species:ncbi:10090">mouse</span>
To identify TTGs we optimized parameters of the score of potential function (SPF) (equation 1) to distinguish best between training and control sets of genes. Training sets were genes that were down-regulated or up-regulated by at least 2 fold and responded non-transiently to Pou5f1 suppression within the time window from 6 to 48 hr (Additional file 11). Genes that responded too early (< 6 hr) were not included in the training set because there may have been not enough time for the concentration of Pou5f1 protein to drop substantially (see Additional file 3), and therefore the response may have been caused by other factors. Similarly genes that responded late (> 48) were not included in the training set because many of them may be affected indirectly. The set of control genes was defined as a set of genes with high-quality or medium-quality promoters [17]which did not respond to suppression of Pou5f1 in ZHBTc4 ES cells (FDR > 0.05) and were not differentially expressed between ES and TS cells (FDR > 0.05) [19]. Pou5f1 gene is expressed in ES cells but not in TS cells [57], therefore we expected that the expression of Pou5f1 target genes was different in these types of cells. No change in gene expression measured by microarray may have resulted from non-responding oligos. Thus, we further narrowed down the list of control genes to those genes that showed differential expression (FDR </= 0.05 and > 1.5 fold change) between ovary and testis measured with the same array platform [11] to confirm the functionality of oligos. SPF was estimated based on the strength of Pou5f1 and Nanog binding [1], distance from TSS, and CpG-richness of the DNA region. TSS coordinates in mouse genome assembly mm6 were taken from [17], and coordinates of ChIP-PET regions were converted to genome version mm6 using UCSC batch conversion tool [58]. Association between binding sites and TSSs was established using the following rules: (1) if distance to TSS of gene A was > 3 fold greater than distance to TSS of gene B, then binding site was associated only with gene B, otherwise it was associated with both A and B; (2) if genes A and B have a common bidirectional promoter with distance between TSSs < 1 K then binding sites were associated with both genes; (3) non-RefSeq genes were ignored unless they responded to Pou5f1 manipulation (this rule was needed to avoid association with antisense regulatory transcripts); and (4) distance between binding site and TSS was limited to 200 K. CpG-rich regions were those that contained minimum of 8 CpG pairs within 250 bp [17]. Initially we included the effect of repeats and binding motifs in SPF, but then we removed them because they were not significant. Optimization was done separately for 2 training sets of genes that were down-regulated and up-regulated after suppression of Pou5f1. To optimize the parameters of the SPF we used the simplex method implemented in a Perl script based on the published algorithm [59]. At each step of optimization, scores were re-calculated according to modified parameters, binding sites with the highest score were selected for each gene, and then these scores were compared between training genes and control genes using t-statistics. To avoid a circular reference by estimating SPF for genes in the training and control set with parameters optimized for the same genes, we used the bootstrap resampling method [20]. Both training and control sets of genes were randomly split into 10 portions, and optimization was repeated 10 times with one portion of training and control genes excluded. Then, parameters (a, b, c, and d) in equation (1) were averaged; however when estimating SPFs for genes that belong to the i-th portion of training or control genes we averaged only those values that were optimized without the i-th portion of genes. The probability distribution of binding scores among control genes was used for estimating the p-value, and then the FDR was estimated using the method of [21] in each group of genes that differ by time, direction, and magnitude of response to manipulation of the TF. TTGs were selected using FDR = 0.2 as a threshold. Because each group has a large number of genes (median = 160), FDR in each group can be interpreted as the proportion of false positives among genes that are assumed significant in this group. Thus, the total proportion of false positives among pooled significant genes from all groups should also be close to the FDR threshold. This method is based on the assumption that SPF represents correctly the role of binding sites in transcription regulation. This assumption is not always true because SPF estimation is based on the limited information that is available; thus binding sites with the highest SPF for each gene are not necessary the ones that act as main regulatory switches. The quality of analysis can be improved as additional information becomes available (e.g., luciferase assay and location of insulators).
###end p 64
###begin title 65
Numerical examples
###end title 65
###begin p 66
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 2137 2139 2137 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
The purpose of these examples is to show the advantage of the proposed method for detecting direct target genes compared to the traditional approach when all genes that responded to manipulation of a TF and have a binding site in their promoter are considered direct targets. Our method for identification of direct targets of a TF is based on splitting the genes that responded to TF manipulation into groups according to the direction, magnitude and time of their response, and then applying the FDR criterion within each group (Fig. 1). In the first example we assume that all true binding sites are known, and therefore there is no need for using SPF. There are 5000 genes that responded to manipulation of TF which are split into 10 groups according to the direction, magnitude and time of response. For simplicity we assume that all groups have equal number of genes, and only 2 of these groups contained true direct target genes. The proportion of target genes in these 2 groups was 40% and in other groups it was 0%. Binding sites are present in promoters of all true target genes and in 20% of other genes (non-functional binding). If we consider all responding genes with binding sites as TTGs, then we would find 1320 of these genes which include 69.7% of false positives. Using our approach, we select genes with binding sites only in 2 groups of responding genes that had a significantly higher proportion of genes with binding sites (52% versus 20% in control). As a result, 520 TTGs are detected and they contain only 23% of false positives. Here our method yielded a 3-fold reduction in the proportion of false positives. The second example, which is more realistic, assumes that there is no clear-cut distinction between true and false binding sites. Instead, binding sites are characterized quantitatively by SPF. We modify the previous example by assuming that true target genes have a normal distribution of SPF with M = 7 and SD = 2, whereas other genes have a normal distribution of SPF with M = 3 and SD = 2. Assuming that we can tolerate 25% of false positives, we set FDR threshold to 0.25. Using the method of [21] and p-values from the probability distribution of SPF in control genes, we estimated that this FDR = 0.25 corresponds to the threshold of SPF = 5.75 in groups that contain true target genes, and is unattainable in groups without true target genes. As a result, 347 TTGs are identified, and 52 of them are false positives (15%). Proposed method reduced the proportion of false positives by > 3 fold and increased the number of identified true target genes by 47%. The actual proportion of false positives appeared slightly lower than the target FDR rate because we assumed that the distribution of SPF among true targets is unknown.
###end p 66
###begin title 67
Real-time quantitative RT-PCR
###end title 67
###begin p 68
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2 </italic>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
Primers for quantitative reverse transcriptase PCR (qRT-PCR) were designed and tested for SYBR Green chemistry using an established in-house protocol [57]. Primers for Cdx2 were ACGTACATGGTGGCGAGGGA (forward), and GGGAGGCAGAAGCTCTGCAA (reverse), and primers for Nanog were CTGGGAACGCCTCATCAA (forward), and CATCTTCTGCTTCCTGGCAA (reverse). Primers for Pou5f1 (transgene-specific) were ACGAGTGGAAAGCAACTCA and AGATGGTGGTCTGGCTGAAC. Total RNA was used to prepare cDNA as described previously [57]. Reactions were run on ABI 7900 HT Sequence Detection Systems using the default cycling program, and data were processed using SDS 2.2 software (Applied Biosystems).
###end p 68
###begin title 69
Western blot analysis
###end title 69
###begin p 70
Protein amounts of each sample were quantified using the RC DC protein assay kit (Bio-Rad, 500-0119). For western blotting, the samples were boiled for 5 min and loaded onto a 8-16% SDS-polyacrylamide gel. The electrophoretically separated proteins were transferred to immobilon-P membrane (Millipore). The membrane filters were blocked with PBST (1x PBS, 0.05% Tween 20) containing 5% nonfat milk powder (PBST-Milk) at room temperature for 1 h and then washed three times each with PBS-T for 5 min. The primary antibodies against POU5F1 (sc-5279, Santa Cruz Biotechnology, Inc.) and UBTF (UBF) (sc-13125, Santa Cruz Biotechnology, Inc.) diluted at 1:10000 in PBST-Milk were applied at room temperature for 1 h. After three washes with the PBS-T, the secondary HRP-conjugated IgG (1:3000 dilution) in PBST-Milk was applied at room temperature with agitation for 30 minutes. The filters were washed again, treated with the ECL Western Blotting Detection Reagents (GE Healthcare, USA), and exposed to a film for visualization.
###end p 70
###begin title 71
Abbreviations
###end title 71
###begin p 72
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
ChIP, chromatin-immunoprecipitation; ES, embryonic stem (cells); FDR, false discovery rate; GO, gene ontology; MEF, mouse embryonic fibroblast; NS, neural stem (cells); PCA, principal component analysis; SPF, score of potential function (for binding sites); TF, transcription factor; TS, trophoblast stem (cells); TSS, transcription start site; TTG, tentative target gene.
###end p 72
###begin title 73
Authors' contributions
###end title 73
###begin p 74
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 421 428 421 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
AAS developed the method for identification of target genes of transcription factors, carried out statistical and bioinformatics analysis, and wrote the paper. SM carried out the experiment on suppression of Pou5f1 and Sox2 expression in ES cells. LVS carried out the experiment on Nanog over-expression and did PCR. YP labeled and hybridized probes to microarrays. KA and RM carried out the experiment on suppression of Pou5f1 expression in ES cells. LX performed Western blot for POU5F1. HN developed inducible knockout cell lines. MSHK coordinated the project and edited the manuscript. All authors read and approved the final manuscript.
###end p 74
###begin title 75
Supplementary Material
###end title 75
###begin title 76
Additional file 1
###end title 76
###begin p 77
Summary of data used in this study
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Additional file 2
###end title 79
###begin p 80
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1</italic>
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Log-transformed gene expression data for non-redundant genes in ZHBTc4 cell line after suppression of <italic>Pou5f1</italic></bold>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Log-transformed gene expression data for non-redundant genes in ZHBTc4 cell line after suppression of Pou5f1. The time series was combined from 2 data sets: (1) data for 0, 3, 6, 12, and 24 hr after adding tetracycline analyzed with NIA 44 k array (probe names in the 1st column), and (2) data for 0, 24, 48, 72, 96, and 120 hr are from the experiment of [2] analyzed with NIA 22 k Dev-2 array (probe names are in column 24).
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Additional file 3
###end title 82
###begin p 83
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Suppression of tet-inducible transgene <italic>Pou5f1 </italic>in ZHBTc4 ES cells in a time course after adding tetracycline to the media</bold>
Suppression of tet-inducible transgene Pou5f1 in ZHBTc4 ES cells in a time course after adding tetracycline to the media. (A) Log expression change from microarray data (log10), oligo is in ORF. (B) Expression change in real-time PCR data normalized by expression in parental EB5 cell line, primers are in transgene-specific region. (C) Western blot showing decrease in POU5F1 protein amount, UBTF is used as a control.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Additional file 4
###end title 85
###begin p 86
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
Genes that responded to Pou5f1 suppression in ZHBTc4 ES cells
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional file 5
###end title 88
###begin p 89
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of genes that responded to <italic>Pou5f1 </italic>suppression in various studies</bold>
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 345 352 345 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Comparison of genes that responded to Pou5f1 suppression in various studies. (A) Venn diagram of genes that responded to Pou5f1 suppression by > 2 fold in our experiment with tet-inducible ES cell line ZHBTc4 and in published studies of [5,1], which used shRNA as a method of Pou5f1 suppression. (B) Scatter-plot of gene expression change after Pou5f1 suppression in this study and in [1] based on 1225 common genes.
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 6
###end title 91
###begin p 92
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
Genes that responded to Sox2 suppression in 2TS22C ES cells (data from [16])
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Additional file 7
###end title 94
###begin p 95
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Genes that responded to Nanog suppression with shRNA in ES cells (analysis of data from [5])
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional file 8
###end title 97
###begin p 98
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Genes that responded to Nanog suppression with shRNA in ES cells (analysis of data from [1])
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Additional file 9
###end title 100
###begin p 101
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
Genes that responded to Nanog overexpression in ES cells
###end p 101
###begin p 102
Click here for file
###end p 102
###begin title 103
Additional file 10
###end title 103
###begin p 104
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Co-localization of POU5F1 and NANOG binding sites in the mouse genome based on ChIP-PET data from </bold>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 617 619 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 754 755 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Co-localization of POU5F1 and NANOG binding sites in the mouse genome based on ChIP-PET data from [1]. (A) Proportion of ChIP-POU5F1 regions with different number of ditags that were co-localized (withn 1 Kb) with ChIP-NANOG regions (number of ditags indicates binding strength); (B) Density distribution of OCT-SOX composite binding motifs at various distances from the binding site identified with ChIP-PET [1] estimated for groups of genes with >/= 4 POU5F1 ditags, with >/= 4 NANOG ditags, and with >/= 4 NANOG ditags and no POU5F1 ditags. Search for binding motifs was done using components of CisView software [17], which combines pattern-matching and position-weight matrix (PWM) approaches. PWM for OCT-SOX composite binding site was taken from [1].
###end p 104
###begin p 105
Click here for file
###end p 105
###begin title 106
Additional file 11
###end title 106
###begin p 107
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
Sets of training genes that responded to Pou5f1 suppression and control genes used for optimizing the score of potential functionality of binding sites
###end p 107
###begin p 108
Click here for file
###end p 108
###begin title 109
Additional file 12
###end title 109
###begin p 110
Parameters of equation for the score of potential functionality (SPF)
###end p 110
###begin p 111
Click here for file
###end p 111
###begin title 112
Additional file 13
###end title 112
###begin p 113
POU5F1 binding sites with the highest score of potential functionality (SPF) for each gene
###end p 113
###begin p 114
Click here for file
###end p 114
###begin title 115
Additional file 14
###end title 115
###begin p 116
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
ChIP-PET regions (from [1]) listed in Additional file 8
###end p 116
###begin p 117
Click here for file
###end p 117
###begin title 118
Additional file 15
###end title 118
###begin p 119
###xml 0 156 0 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Regression of the cumulative proportion of control genes (p) versus the score of potential function (SPF) of their binding regions identified with ChIP-PET </bold>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Regression of the cumulative proportion of control genes (p) versus the score of potential function (SPF) of their binding regions identified with ChIP-PET [1]. Cumulative proportion of genes was estimated after sorting them by decreasing SPF. Magenta line shows the regression estimated using top 300 genes with highest SPF. (A) SPF parameters estimated by optimization against down-regulated genes; (B) SPF parameters estimated by optimization against up-regulated genes.
###end p 119
###begin p 120
Click here for file
###end p 120
###begin title 121
Additional file 16
###end title 121
###begin p 122
Additional tentative target genes for POU5F1.
###end p 122
###begin p 123
Click here for file
###end p 123
###begin title 124
Additional file 17
###end title 124
###begin p 125
Comparison of tentative target genes of POU5F1 identified in this paper with previously published lists of genes
###end p 125
###begin p 126
Click here for file
###end p 126
###begin title 127
Additional file 18
###end title 127
###begin p 128
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Frequency distribution of a score [SPF.abs(logratio)] among tentative target genes TTGs of POU5F1 identified in this paper and TTGs (non-matching with ours) from [1,2]
###end p 128
###begin p 129
Click here for file
###end p 129
###begin title 130
Additional file 19
###end title 130
###begin p 131
Gene Ontology (GO) annotations of POU5F1 tentative target genes
###end p 131
###begin p 132
Click here for file
###end p 132
###begin title 133
Additional file 20
###end title 133
###begin p 134
Venn diagram of tentative target genes (TTGs) of POU5F1, SOX2, and NANOG
###end p 134
###begin p 135
Click here for file
###end p 135
###begin title 136
Additional file 21
###end title 136
###begin p 137
Combined tentative target genes (TTGs) of POU5F1, SOX2, and NANOG
###end p 137
###begin p 138
Click here for file
###end p 138
###begin title 139
Additional file 22
###end title 139
###begin p 140
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
Additional tentative target genes for SOX2 identified using ChIP data from human ES cells [6] and > 2 fold expression change in mouse ES cells [16]
###end p 140
###begin p 141
Click here for file
###end p 141
###begin title 142
Additional file 23
###end title 142
###begin p 143
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2 </italic>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pou5f1 </italic>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2 </italic>
Expression change of Cdx2 after suppression of Pou5f1 and Sox2 analyzed using quantitative RT-PCR (SE estimated with ANOVA)
###end p 143
###begin p 144
Click here for file
###end p 144
###begin title 145
Acknowledgements
###end title 145
###begin p 146
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
We thank Dawood Dudekula and Yong Qian for helping with bioinformatics analysis and data submission. We thank Dr. Huck-Hui Ng for kindly providing raw data of their published ChIP-PET study [1] and Dr. Ian Chambers for providing a pPyCAGIP plasmid vector. This work was supported by the Intramural Research Program of National Institute on Aging, NIH (Z01 AG000656).
###end p 146
###begin article-title 147
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells
###end article-title 147
###begin article-title 148
Dissecting oct3/4-regulated gene networks in embryonic stem cells by expression profiling
###end article-title 148
###begin article-title 149
How is pluripotency determined and maintained?
###end article-title 149
###begin article-title 150
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
###end article-title 150
###begin article-title 151
Dissecting self-renewal in stem cells with RNA interference
###end article-title 151
###begin article-title 152
###xml 45 50 <span type="species:ncbi:9606">human</span>
Core transcriptional regulatory circuitry in human embryonic stem cells
###end article-title 152
###begin article-title 153
A protein interaction network for pluripotency of embryonic stem cells
###end article-title 153
###begin article-title 154
Transcriptional regulation of nanog by OCT4 and SOX2
###end article-title 154
###begin article-title 155
Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers
###end article-title 155
###begin article-title 156
Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells
###end article-title 156
###begin article-title 157
Effects of aging and calorie restriction on the global gene expression profiles of testis and ovary
###end article-title 157
###begin article-title 158
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
Two yeast forkhead genes regulate the cell cycle and pseudohyphal growth
###end article-title 158
###begin article-title 159
K-ary clustering with optimal leaf ordering for gene expression data
###end article-title 159
###begin article-title 160
Clustering of time-course gene expression data using a mixed-effects model with B-splines
###end article-title 160
###begin article-title 161
Significance analysis of time course microarray experiments
###end article-title 161
###begin article-title 162
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells
###end article-title 162
###begin article-title 163
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
CisView: a browser and database of cis-regulatory modules predicted in the mouse genome
###end article-title 163
###begin article-title 164
Molecular control of pluripotency
###end article-title 164
###begin article-title 165
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Transcript copy number estimation using a mouse whole-genome oligonucleotide microarray
###end article-title 165
###begin article-title 166
Controlling the false discovery rate - a practical and powerful approach to multiple testing
###end article-title 166
###begin article-title 167
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Meta-analysis of differentiating mouse embryonic stem cell gene expression kinetics reveals early change of a small gene set
###end article-title 167
###begin article-title 168
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Polycomb complexes repress developmental regulators in murine embryonic stem cells
###end article-title 168
###begin article-title 169
###xml 12 17 <span type="species:ncbi:9606">human</span>
A family of human zinc finger proteins that bind methylated DNA and repress transcription
###end article-title 169
###begin article-title 170
Targeting of Kruppel-associated box-containing zinc finger proteins to centromeric heterochromatin. Implication for the gene silencing mechanisms
###end article-title 170
###begin article-title 171
The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene
###end article-title 171
###begin article-title 172
Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Sp1 site and downstream gastrin responsive elements
###end article-title 172
###begin article-title 173
###xml 79 84 <span type="species:ncbi:9606">human</span>
Loss of Kruppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression
###end article-title 173
###begin article-title 174
Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells
###end article-title 174
###begin article-title 175
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human heterochromatin proteins form large domains containing KRAB-ZNF genes
###end article-title 175
###begin article-title 176
Oct4 targets regulatory nodes to modulate stem cell function
###end article-title 176
###begin article-title 177
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b
###end article-title 177
###begin article-title 178
Cdyl: a new transcriptional co-repressor
###end article-title 178
###begin article-title 179
Regulation of histone methylation by demethylimination and demethylation
###end article-title 179
###begin article-title 180
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-beta signaling
###end article-title 180
###begin article-title 181
Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation
###end article-title 181
###begin article-title 182
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells
###end article-title 182
###begin article-title 183
Alteration of cell adhesion and cell cycle properties of ES cells by an inducible dominant interfering Myb mutant
###end article-title 183
###begin article-title 184
Cell cycle regulation by the B-Myb transcription factor
###end article-title 184
###begin article-title 185
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
###end article-title 185
###begin article-title 186
Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells
###end article-title 186
###begin article-title 187
Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells
###end article-title 187
###begin article-title 188
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
New cell lines from mouse epiblast share defining features with human embryonic stem cells
###end article-title 188
###begin article-title 189
Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity
###end article-title 189
###begin article-title 190
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Defining a developmental path to neural fate by global expression profiling of mouse embryonic stem cells and adult neural stem/progenitor cells
###end article-title 190
###begin article-title 191
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain
###end article-title 191
###begin article-title 192
The Sox2 regulatory region 2 functions as a neural stem cell-specific enhancer in the telencephalon
###end article-title 192
###begin article-title 193
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells
###end article-title 193
###begin article-title 194
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
A polyoma-based episomal vector efficiently expresses exogenous genes in mouse embryonic stem cells
###end article-title 194
###begin article-title 195
NCBI GEO: mining tens of millions of expression profiles-database and tools update
###end article-title 195
###begin article-title 196
Gene Expression Omnibus
###end article-title 196
###begin article-title 197
A web-based tool for principal component and significance analysis of microarray data
###end article-title 197
###begin article-title 198
NIA Array Analysis
###end article-title 198
###begin article-title 199
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains
###end article-title 199
###begin article-title 200
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Genome-wide assembly and analysis of alternative transcripts in mouse
###end article-title 200
###begin article-title 201
###xml 4 9 <span type="species:ncbi:10090">Mouse</span>
NIA Mouse Gene Index (mm8)
###end article-title 201
###begin article-title 202
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling
###end article-title 202
###begin article-title 203
UCSC batch conversion tool
###end article-title 203

